7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
    1.
    发明授权
    7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders 失效
    作为用于治疗神经变性疾病的c-Jun N-末端激酶的抑制剂的7-氮杂吲哚

    公开(公告)号:US07534800B2

    公开(公告)日:2009-05-19

    申请号:US10509128

    申请日:2003-03-17

    IPC分类号: A01N43/42 C07D221/02

    CPC分类号: C07D471/04

    摘要: The present invention relates to novel 3,5-substituted 7-azaindole compounds of formula (I), their use in the inhibition of c-Jun N-terminal kinases, their use in medecine and particularly in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation. The invention also provides processes for manufacture of said compounds, compositions containing them and processes for manufacturing such compositions.

    摘要翻译: 本发明涉及式(I)的新颖的3,5-取代的7-氮杂吲哚化合物,其用于抑制c-Jun N-末端激酶,其在中间体中的用途,特别是在预防和/或治疗神经变性 与凋亡和/或炎症相关的疾病。 本发明还提供了用于制备所述化合物的方法,含有它们的组合物和用于制备这种组合物的方法。

    JNK inhibitors
    3.
    发明授权
    JNK inhibitors 失效
    JNK抑制剂

    公开(公告)号:US07612086B2

    公开(公告)日:2009-11-03

    申请号:US10554808

    申请日:2004-05-14

    CPC分类号: C07D471/04

    摘要: The present invention provides novel compounds of formula (I) and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.

    摘要翻译: 本发明提供新的式(I)化合物及其在抑制c-Jun N-末端激酶中的用途。 本发明进一步提供这些化合物在药物中的用途,特别是在预防和/或治疗与凋亡和/或炎症相关的神经变性疾病中的用途。